Clinical Trials | November 27, 2025
NHS’s breakthrough leukaemia therapy set to transform lives in UK
Clinical trials found that 77% of patients went into remission after receiving obe-cel
Clinical trials found that 77% of patients went into remission after receiving obe-cel
Itvisma is a one-time, fixed-dose therapy designed to tackle the genetic root cause of SMA
Desai is currently serving the company as Group Finance Controller
HER2-mutant NSCLC typically has a poor prognosis and limited treatment options
Innovent plans to soon submit a new drug application (NDA) to China’s National Medical Products Administration
_256_384.png)
India presents one of the world’s largest untapped opportunities for neurovascular screening
Stivarga is the standard third-line treatment for metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma
Cardiovascular disease (CVD) is the leading cause of death in the US and worldwide with over 82 million Americans living with CVD
The data highlight sustained intraocular pressure (IOP) reduction, drop-free treatment outcomes, and strong visual performance
Patients on baxdrostat showed a significant reduction in systolic blood pressure (SBP) compared to placebo
Subscribe To Our Newsletter & Stay Updated
